Skip to main content
. 2021 May 10;87(12):4598–4607. doi: 10.1111/bcp.14873

FIGURE 2.

FIGURE 2

Cohort analysis for 30‐day mortality following COVID‐19 diagnosis showing unadjusted hazard ratios (grey) and model adjusted for body mass index, blood pressure, smoking status, frailty level, comorbidities and practice region (blue). ACEI, angiotensin‐converting enzyme inhibitor; AHT, antihypertensive treatment; ARB, angiotensin receptor blocker; HR, hazard ratio; LL, lower limit 95% confidence interval; UL, upper limit 95% confidence interval